There is much current interest in the entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) which is heralded as a major advance for the prevention of sudden cardiac death in selected patients.
ARWatch
Progress in subcutaneous lead ICD devices
IN THIS ISSUE
Positive NICE Final Appraisal For Dronedarone
The National Institute for Health and Clinical Excellence (NICE) has issued its final appraisal determination on dronedarone (Multaq) recommending the drug as an option for non-permanent atrial fibrillation (AF) in selected patients. (1)
Medtronic Develops New Paediatric Oxygenator
Great Ormond Street Hospital for Children NHS Trust, has successfully used the new Affinity PixieTM paediatric oxygenator from Medtronic in its first clinical cases for infant and paediatric heart surgery.
ZOLL Medical awarded BHF tender for AEDS
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, has announced that it has been designated a nominated supplier by the British Heart Foundation (BHF) for its ZOLL (Automatic external defibrillator) AED Plus® and ZOLL AED Pro®.
Congress Report: European Neurological Society (ENS) 2010: 3,000 neurologists meet in Berlin
“Worldwide, strokes are the most common cause of death. This makes it a top priority for medicine to expand prevention in this area,” said Prof. Dr. Karl Max Einhäupl, from the University Clinic Charité in Berlin, who is co-chair of the Annual Meeting of the European Neurological Society (ENS) which took place in Berlin recently.
Guidelines on Cardiovascular Fitness to Fly produced.
Over 200 million people fly through British airports each year – many with heart disease. How do these patients with heart disease know whether they can fly safely or whether flying might pose risks to their health?
Telehealth patients experience improvement in care and quality of life
Heart failure patients who used an interactive telehealth system with motivational support tools at home spent less time in hospital and felt their quality of life had significantly improved over 12 months evaluation period, according to the final results of the CARME (CAtalan Remote Management Evaluation) study.
CURRENT NEWS
CLARITY-AF Study Underway
Enrolement is Underway in the CLARITY-AF Study which compares Efficacy, safety and efficiency of two catheter ablation technologies.
RCP Mersey Revalidation Appraisal Pilot Completed
The RCP piloted the GMC Appraisal Framework in secondary care in the Mersey region on behalf of the Revalidation Support Team (RST) and the report was presented recently to the UK Programme Board.
RCP backs DH White Paper
“‘The plans set out in the White Paper, (‘Liberating the NHS’) represent a welcome shift towards a greater focus on measuring health services on grounds of quality and outcomes rather than on activity and process targets” said Professor Sir Ian Gilmore, President of the Royal College of Physicians (RCP).
Atrial fibrillation, and hypertension
“Hypertension is the most prevalent risk factor leading to the development of atrial fibrillation (AF), the most common arrhythmia” according to Dr I Grundvold, University of Oslo.
“NICE” population approach, a model for European cardiovascular prevention?
The European Society of Cardiology (ESC) has welcomed the publication of the National Institute for Health and Clinical Excellence (NICE) public health guidance on prevention of cardiovascular disease (CVD) at the population level in UK.
MADIT-CRT shows women have greater benefit from CRT-D’s
Recently announced results from a sub-analysis of the MADIT-CRT trial data that show that women receive a greater clinical benefit from cardiac resynchronization therapy defibrillators (CRT-Ds) than men. The results were presented during the 17th Cardiostim World Congress by Jonathan Steinberg, M.D., Chief of Cardiology and Director of the Al-Sabah Arrythmia Institute, St. Luke’s-Roosevelt Hospital Center, New York.
Contrast-induced nephropathy (CIN) reduced with iodixanol
Results from the largest comparative, randomized clinical trial of patients who are at risk for contrast-induced nephropathy (CIN) demonstrate that VISIPAQUE™ (iodixanol), an iso-osmolar contrast medium, is associated with a significantly lower incidence of CIN in high-risk elderly patients, compared with low-osmolar iopromide, another commonly used contrast medium.
Personalized medicine set to impact justice system
Enabled by pharmacogenomics, molecular imaging and other molecular biomarkers, personalized medicine promises to optimize modern medicine and minimize the potential side effects of therapeutic agents. A leading pathologist has now indicated that it may also dramatically impact the justice system, and in ways that we are only just beginning to understand.
PCI- safety without surgical cover confirmed
PCI can be performed safely and with significant improvement at centres without a surgical service, according to a study published in the European Journal of Cardiovascular Prevention and Rehabilitation.
There is now little dispute that percutaneous coronary intervention (PCI) has revolutionised the management of patients with acute coronary events such as heart attack. Moreover, improvements in [...]
Members Area
Log in or Register now.
GET EXCLUSIVE UPDATES
Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.
RECENT COMMENTS
- None Found
PROUDLY SPONSORED BY
